Evidence map›Paper›PMID 18184631›Full record

Trial reportBMJ (Clinical research ed.)2008

Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial.

S K Roy, M Jahangir Hossain, Wajiha Khatun, Barnali Chakraborty, S Chowdhury, Afroza Begum, Syeda Mah-e-Muneer, Sohana Shafique, Mansura Khanam, R Chowdhury

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00226616 (Clinical Trial of Zinc Supplementation in Cholera Patients), which is not on this map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00226616 phase3completednot on this map

Clinical Trial of Zinc Supplementation in Cholera Patients

TypeinterventionalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2000 to 2002ConditionsCholeraArmsZinc
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Oral zinc for treating diarrhoea in children.The Cochrane database of systematic reviews · 2016
    Pooled it
  3. Zinc supplements for preventing otitis media.The Cochrane database of systematic reviews · 2014
    Pooled it
  4. Pooled it
  5. Trial
  6. Zinc inhibits cAMP-induced ClAmerican journal of physiology. Cell physiology · 2025
    Article
  7. Metal Ion Signaling in Biomedicine.Chemical reviews · 2025
    Review
  8. Review
  9. Article
  10. Diagnosis, Management, and Future Control of Cholera.Clinical microbiology reviews · 2022
    Review
  11. Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacteriumJournal of enzyme inhibition and medicinal chemistry · 2021
    Article
  12. Review
  13. Article
  14. Cholera.Current epidemiology reports · 2018
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Zinc: Role in the management of diarrhea and cholera.World journal of clinical cases · 2013
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

S K RoyInternational Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B), 68, Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka -1212, Bangladesh. skroy@icddrb.org
M Jahangir Hossain
Wajiha Khatun
Barnali Chakraborty
S Chowdhury
Afroza Begum
Syeda Mah-e-Muneer
Sohana Shafique
Mansura Khanam
R Chowdhury
International Centre for Diarrhoeal Disease Research · BD

Funding

Medical Research Council G0500300
6 · The paper itself

Abstract

objectiveTo investigate the impact of zinc supplementation in children with cholera.

designDouble blind, randomised, placebo controlled trial.

settingDhaka Hospital, Bangladesh.

participants179 children aged 3-14 years with watery diarrhoea and stool dark field examination positive for Vibrio cholerae and confirmed by stool culture.

interventionChildren were randomised to receive 30 mg elemental zinc per day (n=90) or placebo (n=89) until recovery. All children received erythromycin suspension orally in a dose of 12.5 mg/kg every six hours for three days.

main outcome measuresDuration of diarrhoea and stool output. Results 82 children in each group completed the study. More patients in the zinc group than in the control group recovered by two days (49% v 32%, P=0.032) and by three days (81% v 68%, P=0.03). Zinc supplemented patients had 12% shorter duration of diarrhoea than control patients (64.1 v 72.8 h, P=0.028) and 11% less stool output (1.6 v 1.8 kg/day, P=0.039).

conclusionZinc supplementation significantly reduced the duration of diarrhoea and stool output in children with cholera. Children with cholera should be supplemented with zinc to reduce its duration and severity.

trial registrationClinical trials NCT00226616.

Indexed as

Dietary SupplementsAdolescentAnti-Bacterial AgentsBangladeshChildChild, PreschoolCholeraDiarrheaDouble-Blind MethodDrug Therapy, CombinationErythromycinHumansInfantTreatment OutcomeZincAnti-Bacterial AgentsErythromycinZinc

Identifiers

PMID18184631
PMCPMC2223005
OpenAlexW2125624946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.